Analyzing Healthcare

In this high-impact episode of the Analyzing Healthcare podcast, we sit down with Robbie Allen, CEO of US Heart and Vascular (USHV), to explore how he scaled the cardiology platform from 40 to 400+ providers across six states in just 3.5 years. Robbie shares a behind-the-scenes look at building one of the fastest-growing cardiovascular care organizations in the country.

This episode dives into key themes shaping the future of cardiology and multi-site specialty care—value-based care models, digital health, health equity, access expansion, provider network growth, and legislative challenges. We also examine how technology, AI, and strategic MSO models are reshaping patient experience and healthcare delivery at scale.

Whether you're a healthcare executive, MSO operator, cardiologist, policy expert, or investor, this conversation offers essential insights on how to scale care delivery models, navigate regulatory hurdles, and position for national and global healthcare transformation.

Title:

How Robbie Allen Scaled US Heart & Vascular 10x — Inside the Future of Cardiology | SCALE Community

Key Timestamps:

• {00:00} Introduction to US Heart and Vascular
• {02:47} Growth and Expansion of USHV’s Platform
• {05:49} Innovations in Patient Care and Technology
• {09:03} Building Value-Based Care and Risk Models
• {11:47} Expanding Access & Health Equity Focus
• {17:42} Strategic Partnerships and MSO Opportunities
• {24:18} Leveraging Technology for Scalable Care
• {27:15} Shaping the Future of Cardiology
• {32:31} Collaboration vs. Competition in the MSO Space
• {34:38} Legislative and Regulatory Considerations
• {41:42} Global Healthcare Trends & Expansion Potential

Key Takeaways:

• US Heart and Vascular grew from 40 to 400+ providers in 3.5 years.
• Focused on expanding care access in underserved markets.
• Uses technology and AI to improve patient experience and operations.
• Developing value-based care and risk-sharing models.
• Health equity is a core organizational priority.
• Promotes collaboration among cardiology providers.
• Shift underway as providers move out of traditional health systems.
• Legislative changes impact MSO operations and strategy.
• Exploring global models to inform U.S. care delivery.
• Emphasizes scalable, sustainable healthcare practices.

About the Guest:

Robbie Allen, CEO of US Heart and Vascular, has scaled the platform from 40 to 400+ providers across six states in just 3.5 years. A seasoned healthcare leader, he champions access, value-based care, and tech-driven innovation. Robbie’s impact spans cardiology, AI health startups, and executive leadership—reshaping the future of specialty care through strategic growth and patient-centric solutions.

In this high-impact episode of the Analyzing Healthcare podcast, we sit down with Robbie Allen, CEO of US Heart and Vascular (USHV), to explore how he scaled the cardiology platform from 40 to 400+ providers across six states in just 3.5 years. Robbie shares a behind-the-scenes look at building one of the fastest-growing cardiovascular care organizations in the country.

This episode dives into key themes shaping the future of cardiology and multi-site specialty care—value-based care models, digital health, health equity, access expansion, provider network growth, and legislative challenges. We also examine how technology, AI, and strategic MSO models are reshaping patient experience and healthcare delivery at scale.

Whether you're a healthcare executive, MSO operator, cardiologist, policy expert, or investor, this conversation offers essential insights on how to scale care delivery models, navigate regulatory hurdles, and position for national and global healthcare transformation.

Title:

How Robbie Allen Scaled US Heart & Vascular 10x — Inside the Future of Cardiology | SCALE Community

Key Timestamps:

• {00:00} Introduction to US Heart and Vascular
• {02:47} Growth and Expansion of USHV’s Platform
• {05:49} Innovations in Patient Care and Technology
• {09:03} Building Value-Based Care and Risk Models
• {11:47} Expanding Access & Health Equity Focus
• {17:42} Strategic Partnerships and MSO Opportunities
• {24:18} Leveraging Technology for Scalable Care
• {27:15} Shaping the Future of Cardiology
• {32:31} Collaboration vs. Competition in the MSO Space
• {34:38} Legislative and Regulatory Considerations
• {41:42} Global Healthcare Trends & Expansion Potential

Key Takeaways:

• US Heart and Vascular grew from 40 to 400+ providers in 3.5 years.

• Focused on expanding care access in underserved markets.

• Uses technology and AI to improve patient experience and operations.

• Developing value-based care and risk-sharing models.

• Health equity is a core organizational priority.

• Promotes collaboration among cardiology providers.

• Shift underway as providers move out of traditional health systems.

• Legislative changes impact MSO operations and strategy.

• Exploring global models to inform U.S. care delivery.

• Emphasizes scalable, sustainable healthcare practices.

About the Guest:
Robbie Allen, CEO of US Heart and Vascular, has scaled the platform from 40 to 400+ providers across six states in just 3.5 years. A seasoned healthcare leader, he champions access, value-based care, and tech-driven innovation. Robbie’s impact spans cardiology, AI health startups, and executive leadership—reshaping the future of specialty care through strategic growth and patient-centric solutions.
🔗 linkedin.com/in/robbieallen7
🔗 linkedin.com/in/jasonschifman

Keywords:
US Heart and Vascular, cardiology, healthcare innovation, value-based care, health equity, technology in healthcare, patient experience, legislative impact, global healthcare, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Board governance, scaling companies, and healthcare strategy with Jan Babiak, former EY leader and Walgreens Boots Alliance board member.

In this compelling episode of the Analyzing Healthcare podcast, Jan Babiak—board leader and former Global Managing Partner at EY—joins Roy Bejarano, Co-Founder of SCALE Healthcare, to explore how governance must evolve as companies grow from startups to $250B+ giants.

Jan breaks down what makes a board high-functioning versus dysfunctional, why diverse skill sets matter, and how board members shape corporate culture and long-term outcomes. With a focus on healthcare, she addresses the unique challenges boards face in this highly regulated and rapidly evolving industry.

From transitioning private companies to public boards, to modernizing consulting and aligning board oversight with mission and innovation—this conversation is a must-listen for leaders at every stage of growth.

Key Timestamps

• {00:00} Introduction to Board Dynamics
• {02:49} Scaling Companies: From Startups to Uber Caps
• {05:45} High Functioning vs. Dysfunctional Boards
• {08:23} The Role of Board Members
• {11:13} Navigating Change in Large Organizations
• {14:05} The Importance of Diverse Skill Sets
• {17:02} The Impact of Governance on Company Culture
• {19:39} Transitioning from Private to Public Boards
• {22:08} Healthcare vs. Other Industries
• {25:00} Consulting in the Modern Era

Top Takeaways

• Board composition evolves significantly as companies scale.
• High-functioning boards foster open dialogue and diverse thinking.
• Dysfunctional boards are often dominated by CEO-driven agendas.
• Effective governance demands understanding organizational complexity.
• Diverse expertise on boards improves innovation and risk management.
• Navigating large-scale change requires adaptability and strategic foresight.
• Healthcare boards face unique pressures due to regulation and patient impact.
• Consulting firms must modernize to stay relevant in dynamic markets.
• Strong governance encourages a transparent and accountable culture.
• Transitioning from private to public boards requires significant shifts in oversight.

Guest Bio – Jan BabiakJan Babiak is a globally respected board director and governance expert. Formerly Global Managing Partner at EY, she now serves on the boards of companies such as Walgreens Boots Alliance. Her work spans digital innovation, risk management, cybersecurity, ESG, and ethics—with a strong lens on the healthcare industry and how effective governance can drive patient-centered, resilient organizations.

Board governance, scaling companies, and healthcare strategy with Jan Babiak, former EY leader and Walgreens Boots Alliance board member.

In this compelling episode of the Analyzing Healthcare podcast, Jan Babiak—board leader and former Global Managing Partner at EY—joins Roy Bejarano, Co-Founder of SCALE Healthcare, to explore how governance must evolve as companies grow from startups to $250B+ giants.

Jan breaks down what makes a board high-functioning versus dysfunctional, why diverse skill sets matter, and how board members shape corporate culture and long-term outcomes. With a focus on healthcare, she addresses the unique challenges boards face in this highly regulated and rapidly evolving industry.

From transitioning private companies to public boards, to modernizing consulting and aligning board oversight with mission and innovation—this conversation is a must-listen for leaders at every stage of growth.

Key Timestamps

• {00:00} Introduction to Board Dynamics
• {02:49} Scaling Companies: From Startups to Uber Caps
• {05:45} High Functioning vs. Dysfunctional Boards
• {08:23} The Role of Board Members
• {11:13} Navigating Change in Large Organizations
• {14:05} The Importance of Diverse Skill Sets
• {17:02} The Impact of Governance on Company Culture
• {19:39} Transitioning from Private to Public Boards

• {22:08} Healthcare vs. Other Industries
• {25:00} Consulting in the Modern Era

Top Takeaways

• Board composition evolves significantly as companies scale.
• High-functioning boards foster open dialogue and diverse thinking.
• Dysfunctional boards are often dominated by CEO-driven agendas.
• Effective governance demands understanding organizational complexity.
• Diverse expertise on boards improves innovation and risk management.
• Navigating large-scale change requires adaptability and strategic foresight.
• Healthcare boards face unique pressures due to regulation and patient impact.
• Consulting firms must modernize to stay relevant in dynamic markets.
• Strong governance encourages a transparent and accountable culture.
• Transitioning from private to public boards requires significant shifts in oversight.

Guest Bio – Jan BabiakJan Babiak is a globally respected board director and governance expert. Formerly Global Managing Partner at EY, she now serves on the boards of companies such as Walgreens Boots Alliance. Her work spans digital innovation, risk management, cybersecurity, ESG, and ethics—with a strong lens on the healthcare industry and how effective governance can drive patient-centered, resilient organizations.
🔗 Connect with Jan Babiak on LinkedIn

About the Host – Roy Bejarano
Roy Bejarano is the Co-Founder and CEO of SCALE Healthcare, the nation’s leading healthcare services consulting firm. As host of the Analyzing Healthcare podcast, Roy convenes top healthcare executives, policy innovators, and thought leaders to challenge conventional thinking and shape the future of healthcare strategy, MSO leadership, and system innovation.
🔗 Connect with Roy Bejarano on LinkedIn

Keywords:Board Dynamics, Scaling Companies, Corporate Governance, High Functioning Boards, Healthcare Strategy, Healthcare Consulting, Organizational Change, Board Members, Company Culture, Corporate Oversight, SCALE Community, Analyzing Healthcare, Roy Bejarano, Jan Babiak, Scale Healthcare

Healthcare System, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Governance, Healthcare Leadership, Latest Trends in Healthcare, Healthcare Board Strategy, MSO Strategy, Healthcare Thought Leadership

Patient Prism uses AI, healthcare analytics, and call center optimization to drive patient engagement, data-driven decisions, and revenue recovery in healthcare.

In this episode of the SCALE Community's Healthcare Podcast, hosted by Roy Bejarano and Jason Schifman, we dive deep into how Patient Prism leverages AI and healthcare analytics to optimize call center operations, drive patient engagement, and unlock real revenue recovery for providers.

Guest Amol Nirgudkar, Founder & CEO of Patient Prism, breaks down the operational barriers in healthcare that prevent converting inquiries into appointments. He shares how real-time call analysis, actionable marketing insights, and sales conversion strategies enable better data-driven decisions, improve lead quality, and enhance the overall patient experience.

The conversation explores the intersection of automation and human touch, measuring ROI and patient lifetime value, and the importance of tech consolidation in modern healthcare environments.

Title:

Operationalizing AI to Boost Patient Engagement & ROI | Amol Nirgudkar, CEO of Patient Prism | SCALE Community

Key Timestamps:

• {00:00} Introduction to Patient Prism and Its Mission
• {05:14} Implementation and Client Engagement with Patient Prism
• {09:54} Marketing Insights and Lead Quality Analysis
• {12:45} Sales Optimization and Conversion Strategies
• {17:55} Operational Challenges and Solutions in Healthcare
• {21:01} Data-Driven Recommendations and Strategic Insights
• {24:09} Maximizing Revenue Potential
• {25:16} Understanding Patient Lifetime Value
• {26:43} Real-Time Insights and Call Analysis
• {28:04} The Future of AI in Healthcare
• {30:45} Balancing Automation and Human Touch
• {34:44} The Importance of Product vs. Feature
• {38:45} Consolidation of Tech Solutions
• {41:12} Expanding Beyond Dental: A Broader Vision
• {44:26} Attribution and Measuring ROI

Key Takeaways:

• Patient Prism applies AI and healthcare analytics to unlock call center optimization and higher sales conversion.
• Understanding lead quality is vital to boosting patient engagement and appointment rates.
• Real-time call analysis and automation drive significant revenue recovery and data-driven decisions.
• Clear insights into patient lifetime value guide better resource allocation.
• Effective marketing insights improve ad spend and ROI attribution across functions.
• Operational inefficiencies—not just poor leads—are major culprits in lost revenue.
• Healthcare organizations benefit from ongoing reporting, strategy, and tech consolidation.
• Balancing AI with human touch is crucial to enhancing the patient experience.
• Scaling solutions beyond DSOs opens new growth in healthcare.
• 
  

About the Guest: Amol is the Founder & CEO of Patient Prism, a pioneering AI-powered healthcare analytics platform helping providers turn calls into care. With a focus on patient engagement, automation, and data-driven decisions, Amol has driven measurable outcomes like 20× ROI and 80% sales conversion rates. He advocates for scalable AI that enhances—rather than replaces—human interaction.

⁠linkedin.com/in/amolnirgudkar⁠

⁠linkedin.com/in/jasonschifman⁠

Keywords: Patient Prism, AI, healthcare analytics, call center optimization, patient experience, marketing insights, sales conversion, operational efficiency, lead quality, data-driven decisions, healthcare, patient engagement, AI, automation, revenue recovery, patient lifetime value, call analysis, tech consolidation, DSO, marketing attribution, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Patient Prism uses AI, healthcare analytics, and call center optimization to drive patient engagement, data-driven decisions, and revenue recovery in healthcare.

In this episode of the SCALE Community's Healthcare Podcast, hosted by Roy Bejarano and Jason Schifman, we dive deep into how Patient Prism leverages AI and healthcare analytics to optimize call center operations, drive patient engagement, and unlock real revenue recovery for providers.

Guest Amol Nirgudkar, Founder & CEO of Patient Prism, breaks down the operational barriers in healthcare that prevent converting inquiries into appointments. He shares how real-time call analysis, actionable marketing insights, and sales conversion strategies enable better data-driven decisions, improve lead quality, and enhance the overall patient experience.

The conversation explores the intersection of automation and human touch, measuring ROI and patient lifetime value, and the importance of tech consolidation in modern healthcare environments.

Title:

Operationalizing AI to Boost Patient Engagement & ROI | Amol Nirgudkar, CEO of Patient Prism | SCALE Community

Key Timestamps:

• {00:00} Introduction to Patient Prism and Its Mission
• {05:14} Implementation and Client Engagement with Patient Prism
• {09:54} Marketing Insights and Lead Quality Analysis
• {12:45} Sales Optimization and Conversion Strategies
• {17:55} Operational Challenges and Solutions in Healthcare
• {21:01} Data-Driven Recommendations and Strategic Insights
• {24:09} Maximizing Revenue Potential
• {25:16} Understanding Patient Lifetime Value
• {26:43} Real-Time Insights and Call Analysis
• {28:04} The Future of AI in Healthcare
• {30:45} Balancing Automation and Human Touch
• {34:44} The Importance of Product vs. Feature
• {38:45} Consolidation of Tech Solutions
• {41:12} Expanding Beyond Dental: A Broader Vision
• {44:26} Attribution and Measuring ROI

Key Takeaways:

• Patient Prism applies AI and healthcare analytics to unlock call center optimization and higher sales conversion.
• Understanding lead quality is vital to boosting patient engagement and appointment rates.
• Real-time call analysis and automation drive significant revenue recovery and data-driven decisions.
• Clear insights into patient lifetime value guide better resource allocation.
• Effective marketing insights improve ad spend and ROI attribution across functions.
• Operational inefficiencies—not just poor leads—are major culprits in lost revenue.
• Healthcare organizations benefit from ongoing reporting, strategy, and tech consolidation.
• Balancing AI with human touch is crucial to enhancing the patient experience.
• Scaling solutions beyond DSOs opens new growth in healthcare.

About the Guest:
Amol is the Founder & CEO of Patient Prism, a pioneering AI-powered healthcare analytics platform helping providers turn calls into care. With a focus on patient engagement, automation, and data-driven decisions, Amol has driven measurable outcomes like 20× ROI and 80% sales conversion rates. He advocates for scalable AI that enhances—rather than replaces—human interaction.

linkedin.com/in/amolnirgudkar

linkedin.com/in/jasonschifman

Keywords:Patient Prism, AI, healthcare analytics, call center optimization, patient experience, marketing insights, sales conversion, operational efficiency, lead quality, data-driven decisions, healthcare, patient engagement, AI, automation, revenue recovery, patient lifetime value, call analysis, tech consolidation, DSO, marketing attribution, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

Description:

In this episode of the SCALE Community Healthcare Podcast, presented by SCALE Healthcare, host Roy Bejarano is joined by award-winning journalist Noam Levey (KFF Health News) for a bold, data-packed discussion on healthcare challenges in the U.S. They dissect how the Affordable Care Act reshaped coverage, why private equity is transforming care delivery, and how predatory patient financing leads to devastating medical debt. They also unpack systemic healthcare costs, the call for transparency, and the role Scale Community can play in advancing sustainable change. This is must-listen content for health policy experts, providers, and change agents committed to a stronger, smarter healthcare system.

Key Timestamps:

• (00:00) Welcome to Scale Community with Roy Bejarano & Healthcare Journalism Journey
• (02:49) Affordable Care Act: Reform Wins & Policy Pitfalls
• (05:55) Why ACA Didn’t Lower Overall Healthcare Costs
• (08:48) Transparency & Systemic Barriers in U.S. Healthcare
• (11:55) Outpatient Growth, Patient Financing & Financial Stress
• (15:01) The Patient Experience & Out-of-Pocket Costs
• (20:52) Private Equity in Healthcare: Ownership Trends
• (25:26) Can Private Equity Enhance Healthcare Transparency?
• (28:03) Patient Financing & Rising Medical Debt Crisis
• (34:01) Demystifying Patient Balances & the Need for Regulation
• (40:28) Healthcare Costs & the Emotional Toll of Medical Debt
• (48:19) A Call from Scale Community: Transparency as a Solution

Key Takeaways:

• The Affordable Care Act increased insurance access but didn’t control rising healthcare costs, especially in outpatient settings.
• Private equity firms now play a dominant role in healthcare, often reducing transparency and increasing system complexity.
• Rising medical debt is fueled by exploitative patient financing schemes and unexpected billing practices.
• Healthcare journalism like Levey’s brings clarity to these trends—offering evidence-based perspectives on reform.
• Roy Bejarano and Scale Community spotlight the need for industry-wide accountability and improved transparency.

Guest Bio:

Noam Levey, senior correspondent at KFF Health News, is one of the most trusted voices in healthcare journalism. With over 15 years at the LA Times, he’s led award-winning investigations on medical debt, the Affordable Care Act, healthcare costs, and transparency. His work continues to shape how Americans and stakeholders understand the modern healthcare landscape. ⁠

Description:
In this episode of the SCALE Community Healthcare Podcast, presented by SCALE Healthcare, host Roy Bejarano is joined by award-winning journalist Noam Levey (KFF Health News) for a bold, data-packed discussion on healthcare challenges in the U.S. They dissect how the Affordable Care Act reshaped coverage, why private equity is transforming care delivery, and how predatory patient financing leads to devastating medical debt.
They also unpack systemic healthcare costs, the call for transparency, and the role Scale Community can play in advancing sustainable change. This is must-listen content for health policy experts, providers, and change agents committed to a stronger, smarter healthcare system.

Key Timestamps:

• (00:00) Welcome to Scale Community with Roy Bejarano & Healthcare Journalism Journey

• (02:49) Affordable Care Act: Reform Wins & Policy Pitfalls

• (05:55) Why ACA Didn’t Lower Overall Healthcare Costs

• (08:48) Transparency & Systemic Barriers in U.S. Healthcare

• (11:55) Outpatient Growth, Patient Financing & Financial Stress

• (15:01) The Patient Experience & Out-of-Pocket Costs

• (20:52) Private Equity in Healthcare: Ownership Trends

• (25:26) Can Private Equity Enhance Healthcare Transparency?

• (28:03) Patient Financing & Rising Medical Debt Crisis

• (34:01) Demystifying Patient Balances & the Need for Regulation

• (40:28) Healthcare Costs & the Emotional Toll of Medical Debt

• (48:19) A Call from Scale Community: Transparency as a Solution

Key Takeaways:

• The Affordable Care Act increased insurance access but didn’t control rising healthcare costs, especially in outpatient settings.

• Private equity firms now play a dominant role in healthcare, often reducing transparency and increasing system complexity.

• Rising medical debt is fueled by exploitative patient financing schemes and unexpected billing practices.

• Healthcare journalism like Levey’s brings clarity to these trends—offering evidence-based perspectives on reform.

• Roy Bejarano and Scale Community spotlight the need for industry-wide accountability and improved transparency.

Guest Bio:
Noam Levey, senior correspondent at KFF Health News, is one of the most trusted voices in healthcare journalism. With over 15 years at the LA Times, he’s led award-winning investigations on medical debt, the Affordable Care Act, healthcare costs, and transparency. His work continues to shape how Americans and stakeholders understand the modern healthcare landscape.

🔗 Connect with Noam Levey on LinkedIn

About the Host:
Roy Bejarano, co-founder of SCALE Healthcare, hosts the SCALE Community Podcast, bringing together thought leaders in healthcare, policy, and innovation to drive impact and challenge status quo thinking.
Connect with Roy Bejarano on LinkedIn

Resource Links:

• KFF Health News – Healthcare Investigations

• More from the SCALE Community Healthcare Podcast

• SCALE Healthcare – Driving Healthcare Innovation

Tags & Keywords (for YouTube & Spotify SEO):
#Healthcare #AffordableCareAct #PrivateEquity #MedicalDebt #PatientFinancing #HealthcareCosts #Transparency #NoamLevey #RoyBejarano #ScaleCommunity #ScaleHealth #HealthcareJournalism #HealthPolicy #SCALEPodcast #BillingTransparency #OutpatientCare #USHealthcare
Healthcare, Affordable Care Act, Noam Levy, Kaiser Family Foundation, healthcare journalism, patient experience, private equity, outpatient care, healthcare costs, healthcare transformation, private equity, healthcare, patient financing, medical debt, transparency, regulation, financial protections, healthcare system, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman.

In this episode of Analyzing Healthcare, brought to you by Scale Community, we sit down with Dr. William Briggs, CEO of Naitive, to explore the frontier of bone health innovation, with a sharp focus on osteoporosis diagnosis, musculoskeletal health, and healthcare technology. Dr. Briggs shares how Naitive is addressing critical gaps in orthopaedic care through a turnkey solution—“Bone Health Service in a Box”—powered by cutting-edge AI. From FDA approval of OsteoSight™ to piloting with leading orthopaedic groups, this conversation delivers actionable healthcare strategies, deep industry insights, and real-world applications for providers, payers, and innovators alike.

Title: Reinventing Musculoskeletal Care with AI - William Briggs, CEO at Naitive x Analyzing Healthcare

Key Timestamps:

• (00:00) Introduction to Naitive & the Future of Bone Health
• (04:27) The Silent Threat: Diagnosing Osteoporosis
• (06:03) Native’s Turnkey Solution for Orthopaedic Practices
• (10:52) Implementing Osteocyte: Integration & Usability
• (20:13) Go-to-Market Strategy & Commercial Potential
• (38:01) Vision Beyond Bones: Joint & Muscle Health Expansion

Key Takeaways:

• Naitive is building scalable solutions in musculoskeletal care, with a specific focus on osteoporosis—a condition that often goes undiagnosed.
• Their AI-powered platform, OsteoSight™, leverages routine imaging data to proactively detect bone loss.
• The company has received FDA Breakthrough Device Designation, reinforcing its potential clinical impact.
• Currently in pilot with leading orthopaedic groups, the implementation process is designed to be seamless and minimally disruptive.
• Dr. Briggs shares insights on whether Naitive will stay purely tech-focused or expand into human-led patient care services.
• The conversation covers market readiness, payer strategy, and what it takes to drive adoption among healthcare stakeholders.

About the Guest:

Dr. William Briggs is a Cambridge-trained physician and biochemist who transitioned from clinical practice in London to healthcare innovation. At Naitive, he developed OsteoSight™, an AI-powered tool that analyzes routine X-rays to detect early signs of osteoporosis, addressing the widespread underdiagnosis of this condition. Under his leadership, OsteoSight™ received FDA Breakthrough Device Designation, marking a significant advancement in proactive bone health management.

⁠linkedin.com/in/will-briggs-76585990⁠

⁠linkedin.com/in/jasonschifman ⁠

Keywords:

Bone Health, Osteoporosis, Naitive, Healthcare Innovation, Orthopaedics, Technology, Diagnosis, Patient Care, FDA Approval, Musculoskeletal Health, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman

In this episode of Analyzing Healthcare, brought to you by Scale Community, we sit down with Dr. William Briggs, CEO of Naitive, to explore the frontier of bone health innovation, with a sharp focus on osteoporosis diagnosis, musculoskeletal health, and healthcare technology. Dr. Briggs shares how Naitive is addressing critical gaps in orthopedic care through a turnkey solution—“Bone Health Service in a Box”—powered by cutting-edge AI. From FDA approval of OsteoSight™ to piloting with leading orthopaedic groups, this conversation delivers actionable healthcare strategies, deep industry insights, and real-world applications for providers, payers, and innovators alike.

Title: Reinventing Musculoskeletal Care with AI - William Briggs, CEO at Naitive x Analyzing Healthcare

Key Timestamps:

• (00:00) Introduction to Naitive & the Future of Bone Health
• (04:27) The Silent Threat: Diagnosing Osteoporosis
• (06:03) Native’s Turnkey Solution for Orthopedic Practices
• (10:52) Implementing Osteocyte: Integration & Usability
• (20:13) Go-to-Market Strategy & Commercial Potential
• (38:01) Vision Beyond Bones: Joint & Muscle Health Expansion

Key Takeaways:

• Naitive is building scalable solutions in musculoskeletal care, with a specific focus on osteoporosis—a condition that often goes undiagnosed.
• Their AI-powered platform, OsteoSight™, leverages routine imaging data to proactively detect bone loss.
• The company has received FDA Breakthrough Device Designation, reinforcing its potential clinical impact.
• Currently in pilot with leading orthopedic groups, the implementation process is designed to be seamless and minimally disruptive.
• Dr. Briggs shares insights on whether Naitive will stay purely tech-focused or expand into human-led patient care services.
• The conversation covers market readiness, payer strategy, and what it takes to drive adoption among healthcare stakeholders.

About the Guest:

Dr. William Briggs is a Cambridge-trained physician and biochemist who transitioned from clinical practice in London to healthcare innovation. At Naitive, he developed OsteoSight™, an AI-powered tool that analyzes routine X-rays to detect early signs of osteoporosis, addressing the widespread under diagnosis of this condition. Under his leadership, OsteoSight™ received FDA Breakthrough Device Designation, marking a significant advancement in proactive bone health management.

linkedin.com/in/will-briggs-76585990

linkedin.com/in/jasonschifman

Keywords:

Bone Health, Osteoporosis, Naitive, Healthcare Innovation, Orthopedics, Technology, Diagnosis, Patient Care, FDA Approval, Musculoskeletal Health, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman